CD32b defines distinct dendritic cell lineages generated from the culture of bone marrow with GM-CSF
-
By
-
Wanho Choi
-
Seul Hye Ryu
-
Ji Soo Park
-
Da Eun Park
-
Min Kyung Chu
-
Hye Young Na
-
Chae Gyu Park
-
May 29, 2026
-
Clinical Scorecard: CD32b Distinguishes Unique Lineages of Dendritic Cells Derived from Bone Marrow Cultured with GM-CSF
At a Glance
| Category | Detail |
|---|
| Condition | Dendritic Cell Development |
| Key Mechanisms | Differentiation of GM-DCs from MDPs and GMPs in response to GM-CSF. |
| Target Population | Mouse models used for dendritic cell research. |
| Care Setting | In vitro bone marrow culture. |
Key Highlights
- Identification of CD32b as a marker for distinct GM-DC subsets.
- CD32b- GM-DCs arise from MDPs within the first week of culture.
- CD32b+ GM-DCs generated from GMPs are numerically dominant later.
- Distinct functions observed between CD32b- and CD32b+ GM-DCs.
- Heterogeneity of GM-DCs demonstrated.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Not applicable; study conducted in mouse models.
GM-CSF used to generate dendritic cells in vitro.
Clinical Best Practices
Related Resources & Content
